Presentation Information

[P2-126]Modulating the immune cell fate with in vivo reprogramming technologies

*Yasuhiro Yamada1 (1. Graduate School of Medicine, The University of Tokyo (Japan))

Login required to view

Login is required to view some content.

Comment

To browse or post comments, you must log in.Log in